|
ARTL Artelo Biosciences Inc 1621221 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,427,000.00 |
| Balance Sheet |
|
Current Assets
|
$4,371,000.00 |
|
Assets
|
$6,459,000.00 |
|
Current Liabilities
|
$1,455,000.00 |
|
Liabilities
|
$1,462,000.00 |
|
Equity
|
$4,997,000.00 |
|
Shares Out
|
673008.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,224,000.00 |
|
Investing Cash Flow
|
$-62,000.00 |
| Market Analysis |
Market Cap
|
$477,835.68 |
|
Price
|
$0.71 |
|
BVPS
|
7.42 |
|
PB
|
0.10 |
|
EPS
|
-0.89 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARTL documents filed with the SEC.
ARTL Filings
Clear
